Ferndale Pharma Group

Ferndale Pharma Group

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Ferndale Pharma Group is a well-established, multi-faceted healthcare organization with a strong commercial footprint. Its business is structured into distinct operating units: Eloquest Healthcare targets hospital-acquired infection prevention; Ferndale Healthcare and Ferndale UK focus on dermatology and topical therapeutic markets; and Ferndale Contract Manufacturing provides CDMO services. With a long operational history and a diversified model spanning proprietary products and services, the company is positioned as a stable, revenue-generating entity in the specialty pharma and topical drug sectors.

DermatologyHospital-Acquired InfectionsAnorectal Disorders

Technology Platform

Vertically integrated expertise in the development, formulation, and manufacturing of topical pharmaceuticals (creams, ointments, gels). Capabilities span from product development through commercial-scale manufacturing and quality control.

Opportunities

Growth in the hospital-acquired infection prevention market driven by cost and safety pressures provides a tailwind for Eloquest Healthcare.
The expanding CDMO sector, especially for topical formulations, offers significant opportunity for the contract manufacturing division to partner with virtual and small biotech companies.

Risk Factors

Intense competition in dermatology and generic markets pressures pricing and market share.
Revenue growth is dependent on successful business development to in-license or acquire new products, creating pipeline risk.
Regulatory changes and reimbursement pressures in healthcare could impact product profitability.

Competitive Landscape

In dermatology, Ferndale competes with large pharma companies (e.g., AbbVie, Pfizer) and pure-play dermatology firms (e.g., Bausch Health's dermatology unit, Ortho Dermatologics). In infection prevention, it competes with larger medtech and pharmaceutical companies. Its CDMO division competes with other topical-focused manufacturers and larger, full-service CDMOs.